fig1
Figure 1. Flowchart of participant enrollment, group allocation, and comparative analysis. MASLD: Metabolic dysfunction-associated steatotic liver disease; SLD: steatotic liver disease; CMRF: cardiometabolic risk factors.
Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Navigation
Navigation
Committee on Publication Ethics
https://members.publicationethics.org/members/metabolism-and-target-organ-damage
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
